Niels C Pedersen

This inventor holds 14 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: University of California, Gilead Sciences, Inc., Other. Active years: 1981-2022.

USPTO Granted Patents = 14

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 183(Granted Patents)

Location History:

Davis, CA (US) (1981)
Winters, CA (US) (1985 - 2011)
Oakland, CA (US) (2020 - 2022)

Company Filing History:

13 out of 15,988

University of California

patents

2 out of 946

Gilead Sciences, Inc.

patents

1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1981-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11260070 - Methods of treating feline coronavirus infections (2022-03-01),

2. 10682368 - Methods of treating feline coronavirus infections (2020-06-16),

3. 7985543 - Test for determining blood type in the cat (2011-07-26),

4. 7482150 - Virulent systemic feline calicivirus (2009-01-27),

5. 7449323 - Hemorrhagic feline calicivirus (2008-11-11),

6. 7309495 - Hemorrhagic feline calicivirus (2007-12-18),

7. 7264816 - Virulent systemic feline calicivirus (2007-09-04),

8. 5565319 - Assay and apparatus for detecting feline immunodeficiency virus (1996-10-15),

9. 5275813 - Methods and compositions for vaccinating against feline immunodeficiency (1994-01-04),

10. 5118602 - Feline T-lymphotropic lentivirus assay (1992-06-02),

11. 5037753 - Feline t-lymphotropic lentivirus (1991-08-06),

12. 4699785 - Cell line producing feline leukemia virus (1987-10-13),

13. 4522810 - Feline calicivirus vaccine (1985-06-11),

14. 4264587 - Vaccine for preventing persistent feline leukemia viremia in cats (1981-04-28),

Title: Niels C Pedersen: Innovator in Feline Coronavirus Treatment

Introduction

Niels C Pedersen is a prominent inventor based in Winters, California, known for his significant contributions to veterinary medicine. With a total of 14 patents to his name, he has made remarkable advancements in the treatment of feline diseases, particularly those caused by coronavirus infections.

Latest Patents

One of Pedersen's latest patents focuses on methods of treating feline coronavirus infections. This patent details the use of carbanucleoside compounds that possess a 1'-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl) substituent, or a pharmaceutically acceptable salt thereof. An exemplary compound mentioned in this patent is (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile. This innovative approach aims to provide effective treatment options for feline patients suffering from coronavirus infections.

Career Highlights

Throughout his career, Niels C Pedersen has worked with esteemed organizations such as the University of California and Gilead Sciences, Inc. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in veterinary medicine.

Collaborations

Pedersen has collaborated with notable colleagues, including Janet K Yamamoto and Janet E Foley. These partnerships have further enhanced his research and development efforts in the treatment of feline diseases.

Conclusion

Niels C Pedersen's innovative work in the field of veterinary medicine, particularly in treating feline coronavirus infections, showcases his dedication to improving animal health. His numerous patents and collaborations reflect his significant impact on the industry.